TrialNature communications2024

Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.

Alexandre Carpentier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.